2607.HK

Shanghai Pharmaceuticals Holding Co., Ltd [2607.HK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

2607.HK Stock Summary

Top 10 Correlated ETFs

2607.HK


Top 10 Correlated Stocks

2607.HK


In the News

2607.HK Financial details

Company Rating
Strong Buy
Market Cap
57.95B
Income
4.6B
Revenue
254.88B
Book val./share
18.72
Cash/share
11.11
Dividend
0.66
Dividend %
5.9%
Employees
47.88K
Optionable
No
Shortable
Yes
Earnings
28 Mar 2024
P/E
8.33
Forward P/E
5.51
PEG
-2.81
P/S
0.22
P/B
0.56
P/C
1.02
P/FCF
13.27
Quick Ratio
1.05
Current Ratio
1.34
Debt / Equity
0.68
LT Debt / Equity
0.11
-
-
EPS (TTM)
1.26
EPS next Y
2.06
EPS next Q
0.6
EPS this Y
-10.06%
EPS next Y
63.7%
EPS next 5Y
63.7%
EPS last 5Y
3.28%
Revenue last 5Y
7.84%
Revenue Q/Q
-2.18%
EPS Q/Q
6.67%
-
-
-
-
SMA20
-6.33%
SMA50
3.36%
SMA100
3.27%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
7%
ROC
0.09%
Gross Margin
12%
Oper. Margin
3%
Profit Margin
2%
Payout
87%
Shs Outstand
4.84B
Shs Float
3.68B
-
-
-
-
Target Price
-
52W Range
10.32-16.6
52W High
-29%
52W Low
+13.6%
RSI
39.23
Rel Volume
0.72
Avg Volume
2.23M
Volume
1.61M
Perf Week
-2.24%
Perf Month
-0.7%
Perf Quarter
-2.24%
Perf Half Y
-8.97%
-
-
-
-
Beta
0.252
-
-
Volatility
0.24%, 0.39%
Prev Close
-1.56%
Price
11.36
Change
-1.22%

2607.HK Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
56.2365.8367.5275.9466.61
Net income per share
1.371.441.581.791.61
Operating cash flow per share
1.112.132.411.781.36
Free cash flow per share
0.421.151.350.330.59
Cash per share
6.15.927.417.4410.63
Book value per share
13.7914.715.9617.3719.26
Tangible book value per share
10.8912.1613.3614.6117.25
Share holders equity per share
13.7914.715.9617.3719.26
Interest debt per share
11.6212.7111.6811.6811.56
Market cap
39.53B38.36B32.57B34.28B39.92B
Enterprise value
52.49B54.83B42.07B43.58B51.08B
P/E ratio
10.189.47.246.737.11
Price to sales ratio
0.250.210.170.160.17
POCF ratio
12.616.374.766.778.42
PFCF ratio
33.1611.738.4936.3719.39
P/B Ratio
1.010.920.720.690.6
PTB ratio
1.010.920.720.690.6
EV to sales
0.330.290.220.20.22
Enterprise value over EBITDA
5.975.073.633.644.25
EV to operating cash flow
16.749.16.158.6110.77
EV to free cash flow
44.0316.7710.9746.2424.81
Earnings yield
0.10.110.140.150.14
Free cash flow yield
0.030.090.120.030.05
Debt to equity
0.810.830.70.640.58
Debt to assets
0.250.250.210.190.19
Net debt to EBITDA
1.481.520.820.780.93
Current ratio
1.361.311.221.271.35
Interest coverage
4.326.355.095.45.34
Income quality
0.71.251.220.810.68
Dividend Yield
0.060.070.070.080.08
Payout ratio
0.610.630.540.530.55
Sales general and administrative to revenue
0.010.010.010.010.01
Research and developement to revenue
0.010.010.010.010.01
Intangibles to total assets
0.120.110.110.110.09
Capex to operating cash flow
-0.62-0.46-0.44-0.81-0.57
Capex to revenue
-0.01-0.01-0.02-0.02-0.01
Capex to depreciation
-1.66-1.46-1.41-1.92-1.21
Stock based compensation to revenue
00000
Graham number
20.6321.8223.8326.4626.43
ROIC
0.060.090.070.080.07
Return on tangible assets
0.030.030.030.030.03
Graham Net
-5.1-6.34-5.77-7.13-2.42
Working capital
24.57B23.48B19.43B24.67B38.82B
Tangible asset value
30.8B34.45B37.98B41.52B60.08B
Net current asset value
12.83B10.45B13.12B12.13B29.38B
Invested capital
0.810.830.70.640.58
Average receivables
41.87B51.13B56.93B62.9B71.26B
Average payables
31.22B36.01B37.33B39.89B46.78B
Average inventory
21.15B24.95B24.48B25.6B30.78B
Days sales outstanding
110.88105.54113.97111.43120.58
Days payables outstanding
93.9784.2583.8781.8593.41
Days of inventory on hand
66.956.8453.4652.8262.42
Receivables turnover
3.293.463.23.283.03
Payables turnover
3.884.334.354.463.91
Inventory turnover
5.466.426.836.915.85
ROE
0.10.10.10.10.08
Capex per share
-0.69-0.97-1.06-1.45-0.77

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
22.1216.4417.9117.9517.74
Net income per share
0.390.230.410.30.32
Operating cash flow per share
0.390.230.411.150.18
Free cash flow per share
0.070.020.220.93-0.03
Cash per share
13.3910.6110.311.5711.11
Book value per share
23.2719.2218.5418.2218.72
Tangible book value per share
20.8317.2216.7916.5217.05
Share holders equity per share
23.2719.2218.5418.2218.72
Interest debt per share
14.0211.1812.1512.6112.93
Market cap
27.93B39.99B47.34B53.02B41.67B
Enterprise value
41.91B51.15B64.74B67.84B59.23B
P/E ratio
6.2412.457.812.148.78
Price to sales ratio
0.440.70.710.80.64
POCF ratio
24.9849.7931.1912.4462.76
PFCF ratio
147.66551.2757.3415.37-356.66
P/B Ratio
0.420.60.690.790.61
PTB ratio
0.420.60.690.790.61
EV to sales
0.670.890.981.020.91
Enterprise value over EBITDA
19.2223.0721.0624.9426.37
EV to operating cash flow
37.4863.6842.6615.9289.2
EV to free cash flow
221.54705.1178.4219.66-506.93
Earnings yield
0.040.020.030.020.03
Free cash flow yield
0.0100.020.070
Debt to equity
0.60.580.650.690.68
Debt to assets
0.20.190.220.220.22
Net debt to EBITDA
6.415.035.665.457.82
Current ratio
1.371.351.381.331.34
Interest coverage
4.653.035.064.394.01
Income quality
1113.90.56
Dividend Yield
0.070.010.010.010.07
Payout ratio
1.780.420.420.252.3
Sales general and administrative to revenue
0.05-0.040.02-0.010.05
Research and developement to revenue
0.010.010.010.010.01
Intangibles to total assets
0.090.090.090.080.08
Capex to operating cash flow
-0.83-0.91-0.46-0.19-1.18
Capex to revenue
-0.01-0.01-0.01-0.01-0.01
Capex to depreciation
0.84-0.360-0.810.78
Stock based compensation to revenue
00000
Graham number
14.359.9813.081111.69
ROIC
0.010.010.020.010.01
Return on tangible assets
0.0100.010.010.01
Graham Net
-1.98-2.41-2.04-2.53-2.44
Working capital
40.08B38.82B42.87B40.44B42.2B
Tangible asset value
59.22B60.08B62.1B61.07B62.4B
Net current asset value
29.47B29.38B31.02B30.41B31.63B
Invested capital
0.60.580.650.690.68
Average receivables
77.12B78.41B81.28B86.75B87.72B
Average payables
46.99B50.39B52.54B54.84B57.54B
Average inventory
28.05B31.41B33.3B32.65B34.1B
Days sales outstanding
114.72120.22116.76118.77121.8
Days payables outstanding
80.1793.6483.6287.2491.39
Days of inventory on hand
46.1862.5850.2451.4954.37
Receivables turnover
0.780.750.770.760.74
Payables turnover
1.120.961.081.030.98
Inventory turnover
1.951.441.791.751.66
ROE
0.020.010.020.020.02
Capex per share
-0.33-0.21-0.19-0.22-0.21

2607.HK Frequently Asked Questions

What is Shanghai Pharmaceuticals Holding Co., Ltd stock symbol ?

Shanghai Pharmaceuticals Holding Co., Ltd is a CN stock and trading under the symbol 2607.HK

What is Shanghai Pharmaceuticals Holding Co., Ltd stock quote today ?

Shanghai Pharmaceuticals Holding Co., Ltd stock price is $11.36 today.

Is Shanghai Pharmaceuticals Holding Co., Ltd stock public?

Yes, Shanghai Pharmaceuticals Holding Co., Ltd is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap